London
· Delayed Price · Currency is GBP · Price in USD Bionano Genomics Statistics
Total Valuation
LON:0A4K has a market cap or net worth of GBP 9.28 million. The enterprise value is 22.70 million.
| Market Cap | 9.28M |
| Enterprise Value | 22.70M |
Important Dates
The next estimated earnings date is Wednesday, May 14, 2025.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +123.37% |
| Shares Change (QoQ) | +15.05% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 2.83M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.38 |
| PB Ratio | 0.33 |
| P/TBV Ratio | 0.45 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.25 |
| EV / Sales | 0.98 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.41 |
Financial Position
The company has a current ratio of 1.06, with a Debt / Equity ratio of 0.77.
| Current Ratio | 1.06 |
| Quick Ratio | 0.38 |
| Debt / Equity | 0.77 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.40 |
| Interest Coverage | -37.46 |
Financial Efficiency
Return on equity (ROE) is -170.33% and return on invested capital (ROIC) is -40.02%.
| Return on Equity (ROE) | -170.33% |
| Return on Assets (ROA) | -32.76% |
| Return on Invested Capital (ROIC) | -40.02% |
| Return on Capital Employed (ROCE) | -193.96% |
| Revenue Per Employee | 248,313 |
| Profits Per Employee | -903,796 |
| Employee Count | 100 |
| Asset Turnover | 0.21 |
| Inventory Turnover | 1.79 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -93.05% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -93.05% |
| 50-Day Moving Average | 12.89 |
| 200-Day Moving Average | 30.70 |
| Relative Strength Index (RSI) | 28.30 |
| Average Volume (20 Days) | 9,566 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 3.07 |
Income Statement
In the last 12 months, LON:0A4K had revenue of GBP 24.58 million and -89.48 million in losses. Loss per share was -70.40.
| Revenue | 24.58M |
| Gross Profit | 303,533 |
| Operating Income | -60.93M |
| Pretax Income | -89.45M |
| Net Income | -89.48M |
| EBITDA | -49.73M |
| EBIT | -60.93M |
| Loss Per Share | -70.40 |
Balance Sheet
The company has 7.57 million in cash and 21.80 million in debt, giving a net cash position of -14.24 million.
| Cash & Cash Equivalents | 7.57M |
| Total Debt | 21.80M |
| Net Cash | -14.24M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 28.26M |
| Book Value Per Share | 15.15 |
| Working Capital | 1.71M |
Cash Flow
In the last 12 months, operating cash flow was -55.05 million and capital expenditures -82,273, giving a free cash flow of -55.14 million.
| Operating Cash Flow | -55.05M |
| Capital Expenditures | -82,273 |
| Free Cash Flow | -55.14M |
| FCF Per Share | n/a |
Margins
| Gross Margin | 1.23% |
| Operating Margin | -247.85% |
| Pretax Margin | -363.87% |
| Profit Margin | n/a |
| EBITDA Margin | -202.29% |
| EBIT Margin | -247.85% |
| FCF Margin | n/a |
Dividends & Yields
LON:0A4K does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -123.37% |
| Shareholder Yield | -123.37% |
| Earnings Yield | -963.98% |
| FCF Yield | -594.01% |
Stock Splits
The last stock split was on January 27, 2025. It was a reverse split with a ratio of 0.0166666667.
| Last Split Date | Jan 27, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.0166666667 |
Scores
LON:0A4K has an Altman Z-Score of -14.84. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -14.84 |
| Piotroski F-Score | n/a |